Heparin: new concepts relevant to clinical use.
D000328:Adult; D000368:Aged; D000925:Anticoagulants / Q000494:pharmacology; D000990:Antithrombin III / Q000037:antagonists & inhibitors; D002561:Cerebrovascular Disorders / Q000188:drug therapy; D055598:Chemical Phenomena; D002621:Chemistry; D004305:Dose-Response Relationship, Drug; D004967:Estrogens / Q000627:therapeutic use; D006207:Half-Life; D006493:Heparin / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D008875:Middle Aged; D009203:Myocardial Infarction / Q000188:drug therapy; D011183:Postoperative Complications / Q000517:prevention & control; D013917:Thrombin / Q000037:antagonists & inhibitors; D013921:Thrombocytopenia / Q000209:etiology; D013923:Thromboembolism / Q000517:prevention & control
D000925:Anticoagulants; D004967:Estrogens; D000990:Antithrombin III; D006493:Heparin; D013917:Thrombin